Home Newsfeeds SVB Leerink Maintains Outperform on Rocket Pharmaceuticals, Lowers Price Target to $64

SVB Leerink Maintains Outperform on Rocket Pharmaceuticals, Lowers Price Target to $64

SVB Leerink analyst Mani Foroohar maintains Rocket Pharmaceuticals (NASDAQ:RCKT) with a Outperform and lowers the price target from $66 to $64.

byBenzinga Newsdesk

July 6, 2022

1 minute read

SVB Leerink analyst Mani Foroohar maintains Rocket Pharmaceuticals (NASDAQ:RCKT) with a Outperform and lowers the price target from $66 to $64.

UBS Initiates Coverage On Treehouse Foods with Buy Rating, Announces Price Target of $60

By Benzinga Newsdesk

March 20, 4:43 AM

UBS analyst Cody Ross initiates coverage on Treehouse Foods (NYSE:THS) with a Buy rating and announces Price Target of $60.

THS

Movers
News

What’s Going On With Colombier Acquisition (CLBR) Stock?

By Erica Kollmann

July 18, 11:31 AM

Colombier Acquisition Corporation (NYSE: CLBR) shares are trading higher on Tuesday. The company announced it has received requests to redeem a total of 14,286,259 CLBR public shares, representing 83% of the total public shares of Colombier. What To Know:

CLBR

Analyst Ratings

Critical Insights From ONE Gas Analyst Ratings: What You Need To Know

By Benzinga Insights

April 12, 9:00 AM

5 analysts have shared their evaluations of ONE Gas (NYSE:OGS) during the recent three months, expressing a mix…

OGS

Bellerophon Therapeutics Shares Gained Over 200% Today

By Vandana Singh

January 5, 10:26 AM

Bellerophon Therapeutics Inc (NASDAQ:BLPH) entered into a license agreement for the development and commercialization of INOpulse with Baylor BioSciences.…

BLPH

SVB Leerink Maintains Outperform on Rocket Pharmaceuticals, Lowers Price Target to $64

Related Posts

UBS Initiates Coverage On Treehouse Foods with Buy Rating, Announces Price Target of $60

What’s Going On With Colombier Acquisition (CLBR) Stock?

Critical Insights From ONE Gas Analyst Ratings: What You Need To Know

Bellerophon Therapeutics Shares Gained Over 200% Today